Alpelisib Active Not Recruiting Phase 1 / 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01872260Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
NCT02167854Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer